var data={"title":"Nonlactational mastitis in adults","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Nonlactational mastitis in adults</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/contributors\" class=\"contributor contributor_credentials\">J Michael Dixon, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/contributors\" class=\"contributor contributor_credentials\">Kenneth M Pariser, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/contributors\" class=\"contributor contributor_credentials\">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dd><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mastitis refers to inflammation of the breast tissue that may or may not be accompanied by infection. Mastitis does not necessarily occur during lactation, is not always accompanied by microbial infection, and may not resolve with antibiotics. Forms of nonlactational mastitis include periductal mastitis and idiopathic granulomatous mastitis.</p><p>Issues related to nonlactational mastitis in adults will be reviewed here; issues related to lactational mastitis are discussed separately. (See <a href=\"topic.htm?path=lactational-mastitis\" class=\"medical medical_review\">&quot;Lactational mastitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">PERIDUCTAL MASTITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Periductal mastitis is an inflammatory condition of the subareolar ducts; the cause is unknown. Periductal mastitis primarily affects young women but can occur in men as well.</p><p>The majority of patients with periductal mastitis are smokers. It has been postulated that smoking is associated with damage of the subareolar ducts, with tissue necrosis and subsequent infection [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The toxic substances in cigarette smoke may damage the ducts directly or there may be a localized hypoxic effect. In a study of 139 patients with the clinical or pathologic diagnosis of periductal mastitis, 89 percent were smokers (as compared with 39 percent of age-matched controls). The breast concentrates substances in cigarette smoke; cotinine, a nicotine derivative, has higher concentrations in subareolar ducts than in plasma [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/3-5\" class=\"abstract_t\">3-5</a>].</p><p>Periductal mastitis is also associated with squamous metaplasia, which is likely a consequence of ongoing inflammation. It has been suggested that squamous metaplasia may lead to partial duct obstruction with subsequent dilatation and secondary inflammation and infection [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/2,6,7\" class=\"abstract_t\">2,6,7</a>]. However, as normal ducts are blocked by keratin, it is the author's view that duct obstruction, duct dilatation, and squamous metaplasia are not precursors of periductal inflammation or relevant etiologic factors.</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Periductal mastitis is an inflammatory condition of the subareolar ducts that usually presents with periareolar inflammation [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/1,2,8,9\" class=\"abstract_t\">1,2,8,9</a>]. Secondary infection of inflamed ducts can occur, leading to duct damage and subsequent rupture with abscess formation (<a href=\"image.htm?imageKey=PC%2F76304\" class=\"graphic graphic_picture graphicRef76304 \">picture 1</a>). Such abscesses often drain spontaneously at the edge of the areola. Recurrent abscesses and a draining fistula (ie, communication between a major subareolar duct and the skin) (<a href=\"image.htm?imageKey=PC%2F78199%7EPC%2F58118%7EPC%2F65757%7EPC%2F75481\" class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \">picture 2A-D</a>) can occur [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/3,6,10-12\" class=\"abstract_t\">3,6,10-12</a>]. (See <a href=\"#H7391701\" class=\"local\">'Subareolar abscess and periareolar fistula'</a> below.)</p><p class=\"headingAnchor\" id=\"H12090387\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Periductal mastitis must be distinguished from duct ectasia, which usually affects older women and is characterized by distension of subareolar ducts with fibrosis [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/13\" class=\"abstract_t\">13</a>]. Duct ectasia is associated with creamy or cheesy nipple discharge and nipple inversion (<a href=\"image.htm?imageKey=SURG%2F57055\" class=\"graphic graphic_picture graphicRef57055 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/14\" class=\"abstract_t\">14</a>]. The dilated subareolar ducts may be apparent clinically and visible on imaging [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p>Originally, duct ectasia and periductal mastitis were considered part of the same clinical syndrome and the two terms were used interchangeably. However, duct ectasia is an age-related phenomenon and is not associated with significant periareolar inflammation or infection. Few women with duct ectasia have a history of prior periductal mastitis.</p><p>Periductal mastitis must also be differentiated from breast cancer. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-women-with-suspected-breast-cancer\" class=\"medical medical_review\">&quot;Diagnostic evaluation of women with suspected breast cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12091176\"><span class=\"h2\">Microbiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cultures are positive for pathogenic or potentially pathogenic organisms in 62 to 85 percent of cases [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/17-19\" class=\"abstract_t\">17-19</a>]. In a series of 29 patients with periductal mastitis, pathogenic or potentially pathogenic organisms were observed more frequently in patients with nipple discharge and a periareolar mass than in patients with nipple discharge only (83 versus 27 percent, respectively) [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/17\" class=\"abstract_t\">17</a>].</p><p>The most common organisms are staphylococci, enterococci, anaerobic streptococci, <em>Bacteroides</em>, and <em>Proteus</em>.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Management</span></p><p class=\"headingAnchor\" id=\"H12093066\"><span class=\"h3\">Periductal mastitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Periductal mastitis is usually a chronic problem. In the setting of purulent nipple discharge, Gram stain and culture should be obtained. Approximately half of the cases resolve with antibiotic therapy together with needle aspiration or incision and drainage of any associated abscess [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/7\" class=\"abstract_t\">7</a>]. Patients with repeated episodes of periareolar infection warrant surgical treatment with excision of diseased ducts [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"#H7391701\" class=\"local\">'Subareolar abscess and periareolar fistula'</a> below.)</p><p>Empiric antibiotic therapy for periductal mastitis consists of <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a> (875 mg orally every 12 hours). Reasonable alternative regimens include <a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a> (500 mg orally four times daily) or <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a> (500 mg orally four times daily; with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> [500 mg orally three times daily] if anaerobes are suspected) [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/18,21\" class=\"abstract_t\">18,21</a>]. If risk for methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) is high (<a href=\"image.htm?imageKey=ID%2F53504\" class=\"graphic graphic_table graphicRef53504 \">table 1</a>), <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a> (one double-strength tablet orally twice daily) or <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> (100 mg orally twice daily) is an appropriate regimen. In the setting of beta-lactam hypersensitivity, <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (300 to 450 mg orally three times daily) is a reasonable alternative [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Therapy should be tailored to results of Gram stain and culture when available.</p><p>The optimal length of therapy is not certain; a 5- to 7-day course can be used if the response to therapy is rapid and complete; if necessary, the duration may be extended to 10 to 14 days.</p><p>Smoking cessation is helpful for reducing the risk of repeat infection [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H7391701\"><span class=\"h3\">Subareolar abscess and periareolar fistula</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of subareolar abscess consists of antibiotic therapy and abscess drainage. Needle aspiration or incision and drainage of an abscess is associated with recurrence of subareolar abscess in up to half of patients [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/3,7\" class=\"abstract_t\">3,7</a>]. Infection recurs because these procedures do not remove the underlying periductal mastitis [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/1-4,22\" class=\"abstract_t\">1-4,22</a>]. In one study, 33 of 67 cases of subareolar abscess were treated successfully with needle aspiration and antibiotics; the other 34 patients required definitive duct excision to healthy tissue [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/7\" class=\"abstract_t\">7</a>]. Similar results have been reported in other clinical series [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/23\" class=\"abstract_t\">23</a>].</p><p>The management of periareolar fistula is laying open the fistula or excision of the fistula tract, usually combined with a total duct excision [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/6-8,23,24\" class=\"abstract_t\">6-8,23,24</a>]. Multiple ducts may be involved with multiple skin openings in some patients; all need to be resected for cure [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/25,26\" class=\"abstract_t\">25,26</a>].</p><p>Total ductal excision can often be performed with local anesthesia and sedation or under general anesthesia as an outpatient procedure. The preferred surgical approach is via a circumareolar incision at the 6 o'clock position, unless a previous scar exists, in which case the scar can be reopened. Dissection is performed underneath the areola and down either side of the major ducts. Curved tissue forceps can be passed around the ducts to facilitate delivery of the ducts into the incision. The ducts are then divided from the undersurface of the nipple and a 2 cm portion of duct is removed (<a href=\"image.htm?imageKey=PC%2F78199%7EPC%2F58118%7EPC%2F65757%7EPC%2F75481\" class=\"graphic graphic_picture graphicRef78199 graphicRef58118 graphicRef65757 graphicRef75481 \">picture 2A-D</a>).</p><p>The back of the nipple must be cleared of all ducts right up to the nipple skin, as infection may recur unless all residual diseased ducts are removed. Sutures rarely, if ever, need to be placed behind the nipple to maintain eversion of the nipple. If the nipple does not evert after resection of the diseased ducts, further dissection and division of fibrous tissue may be required. Subcutaneous tissue can be closed with fine interrupted absorbable sutures and the skin is closed with a running subcuticular absorbable suture. Patients should understand that this procedure results in reduced nipple sensitivity in almost 40 percent of cases [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/27\" class=\"abstract_t\">27</a>].</p><p>Antibiotic treatment for periductal mastitis should be initiated at the time of surgery and be continued postoperatively until all signs of infection have resolved. (See <a href=\"#H12093066\" class=\"local\">'Periductal mastitis'</a> above.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">IDIOPATHIC GRANULOMATOUS MASTITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Idiopathic granulomatous mastitis (IGM), also known as idiopathic granulomatous lobular mastitis, is a rare benign inflammatory breast disease of unknown etiology [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/1,22,28-33\" class=\"abstract_t\">1,22,28-33</a>]. IGM occurs most commonly in parous young women, often within a few years of pregnancy; it can also occur in nulliparous women. There is no increased risk of subsequent breast cancer in patients with IGM.</p><p>Conditions such as tuberculosis, foreign body reaction, granulomatosis with polyangiitis, histoplasmosis, or sarcoidosis may also induce a granulomatous mastitis.</p><p>There may be an association between IGM and <em>Corynebacterium kroppenstedtii</em> infection, especially in the histological pattern termed cystic neutrophilic granulomatous mastitis (CNGM) [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/34-38\" class=\"abstract_t\">34-38</a>]. In addition, mastitis due to <em>C. kroppenstedtii</em> has been associated with elevated prolactin levels [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/39\" class=\"abstract_t\">39</a>].</p><p class=\"headingAnchor\" id=\"H59659171\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IGM may present as a peripheral inflammatory breast mass; it can also present as multiple simultaneous areas of peripheral (and rarely central) infection with abscesses <span class=\"nowrap\">and/or</span> overlying skin inflammation and ulceration (<a href=\"image.htm?imageKey=PC%2F51199\" class=\"graphic graphic_picture graphicRef51199 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/1,28-32\" class=\"abstract_t\">1,28-32</a>]. Nipple retraction, sinus formation, peau d'orange&ndash;like changes, and axillary adenopathy may accompany these findings [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/40-43\" class=\"abstract_t\">40-43</a>]. Women with IGM may develop repeated abscesses over weeks to months. These findings may be confused with breast abscess or malignancy [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/28\" class=\"abstract_t\">28</a>].</p><p>Ultrasound examination typically demonstrates a solid mass, often with one or more abscesses. Mammography may be suggestive of malignancy [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/44-49\" class=\"abstract_t\">44-49</a>].</p><p class=\"headingAnchor\" id=\"H59659178\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of IGM is established via core needle biopsy of a solid mass. The biopsy should be sent for Gram stain, bacterial culture, acid-fast bacilli stain and culture, fungal stain and culture, and histopathology. The microbiology laboratory should be alerted to clinical concern for <em>Corynebacterium</em>.</p><p>Biopsy findings typically demonstrate granulomatous lesions centered on the breast lobule.</p><p>It is also reasonable to obtain a serum prolactin level, given a possible pathogenic link between hyperprolactinemia and IGM [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/39\" class=\"abstract_t\">39</a>].</p><p class=\"headingAnchor\" id=\"H59659186\"><span class=\"h2\">Management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IGM is a self-limiting inflammatory condition that resolves slowly; complete resolution may take 9 to 12 months [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/50\" class=\"abstract_t\">50</a>]. Surgical excision for IGM is often followed by slow wound healing and is not advocated.</p><p>IGM associated with a localized infection usually resolves with antibiotics and drainage [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/8,22,28,30\" class=\"abstract_t\">8,22,28,30</a>]. The approach to antibiotic therapy is as outlined above for periductal mastitis (see <a href=\"#H12093066\" class=\"local\">'Periductal mastitis'</a> above).</p><p>The optimal approach for treatment of <em>Corynebacterium</em> infection is uncertain. If this organism is recovered, we suggest treatment with <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a> (875 mg orally every 12 hours); for penicillin-allergic patients, <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> (100 mg orally twice daily) may be used [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/34,37\" class=\"abstract_t\">34,37</a>]. The optimal length of therapy is not certain; a 5- to 7-day course can be used if the response to therapy is rapid and complete. If necessary, the duration may be extended to 10 to 14 days.</p><p>Localized pain may be managed with nonsteroidal anti-inflammatory drugs (NSAIDs). Routine use of steroids or <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a> is not warranted; these therapies can reduce swelling but may not alter the natural history of the condition, especially in those with small localized lesions. Discontinuation has been associated with rebound inflammation [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/28,46,51-55\" class=\"abstract_t\">28,46,51-55</a>].</p><p>For patients with persistent symptoms and progression of IGM not responding to appropriate antibiotics or with pain uncontrolled with NSAIDs, treatment with steroids, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, or both may be beneficial. In patients with painful, small (&lt;5.0 cm) unilateral lesions with small amounts of drainage or ulceration, treatment with <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> (0.5 <span class=\"nowrap\">mg/kg/day)</span> may be initiated. In patients with multiple lesions, lesions &ge;5 cm in diameter, bilateral lesions, or disease with significant cutaneous ulceration, drainage, or fistulas, treatment with prednisone (0.5 to 1.0 <span class=\"nowrap\">mg/kg/day)</span> may be initiated, with or without methotrexate (10 to 15 mg orally per week, along with daily <a href=\"topic.htm?path=folic-acid-drug-information\" class=\"drug drug_general\">folic acid</a> supplementation) [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/33,51,53,55,56\" class=\"abstract_t\">33,51,53,55,56</a>].</p><p>Patients treated with steroids should begin tapering when erythema and pain have resolved (usually after about four weeks). <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">Prednisone</a> is tapered gradually over 8 to 12 weeks. If flares occur during tapering in patients on steroids alone, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a> (10 to 15 mg per week) may be added. If flares occur during tapering in patients on steroids and methotrexate, small increases in the methotrexate dose (by 2.5 to 5 mg every few weeks) is appropriate. Once clinical remission has been achieved, the methotrexate dose should be reduced monthly; many patients are able to discontinue therapy within 12 months [<a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/57\" class=\"abstract_t\">57</a>].</p><p>Monitoring the lesions with weekly photographs may be helpful. Repeat ultrasonography may be useful if there is suspicion for new lesions or abscess reaccumulation.</p><p class=\"headingAnchor\" id=\"H1001730\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mastitis refers to inflammation of the breast tissue that may or may not be accompanied by infection. Mastitis does not necessarily occur during lactation, is not always accompanied by microbial infection, and may not resolve with antibiotics. Forms of nonlactational mastitis include periductal mastitis and idiopathic granulomatous mastitis. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Periductal mastitis is an inflammatory condition of the subareolar ducts that usually presents with periareolar inflammation. Secondary infection of inflamed ducts can occur, leading to duct damage and subsequent rupture with abscess formation. A draining fistula (ie, communication between a major subareolar duct and the skin) can also develop. (See <a href=\"#H13\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the setting of purulent nipple discharge, Gram stain and culture should be obtained. Cultures are positive for pathogenic or potentially pathogenic organisms in 62 to 85 percent of cases. The most common organisms are staphylococci, enterococci, anaerobic streptococci, <em>Bacteroides</em>, and <em>Proteus</em>. (See <a href=\"#H12091176\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Periductal mastitis is usually a chronic problem. Approximately half of cases resolve with antibiotic therapy together with needle aspiration or incision and drainage. Patients with repeated episodes of periareolar infection warrant surgical treatment with ductal excision. (See <a href=\"#H14\" class=\"local\">'Management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Idiopathic granulomatous mastitis (IGM), also known as idiopathic granulomatous lobular mastitis, is a rare benign inflammatory breast disease of unknown etiology. IGM is most commonly seen in parous young women, often within a few years of pregnancy, although it can occur in nulliparous women. There is no increased risk of subsequent breast cancer in patients with IGM. (See <a href=\"#H18\" class=\"local\">'Idiopathic granulomatous mastitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of IGM is established via core needle biopsy of a solid mass. IGM associated with a localized infection usually resolves with antibiotics and drainage. Surgical excision for IGM is often followed by slow wound healing and is not advocated. (See <a href=\"#H59659178\" class=\"local\">'Diagnosis'</a> above and <a href=\"#H59659186\" class=\"local\">'Management'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Dixon JM. Breast infection. In: ABC of Breast Diseases, Dixon JM (Ed), Blackwell Publishing, Oxford 2006. p.19.</li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/2\" class=\"nounderline abstract_t\">Dixon JM, Ravisekar O, Chetty U, Anderson TJ. Periductal mastitis and duct ectasia: different conditions with different aetiologies. Br J Surg 1996; 83:820.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/3\" class=\"nounderline abstract_t\">Sch&auml;fer P, F&uuml;rrer C, Mermillod B. An association of cigarette smoking with recurrent subareolar breast abscess. Int J Epidemiol 1988; 17:810.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/4\" class=\"nounderline abstract_t\">Bundred NJ, Dover MS, Coley S, Morrison JM. Breast abscesses and cigarette smoking. Br J Surg 1992; 79:58.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/5\" class=\"nounderline abstract_t\">Hill P, Wynder EL. Nicotine and cotinine in breast fluid. Cancer Lett 1979; 6:251.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/6\" class=\"nounderline abstract_t\">ZUSKA JJ, CRILE G Jr, AYRES WW. Fistulas of lactifierous ducts. Am J Surg 1951; 81:312.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/7\" class=\"nounderline abstract_t\">Lannin DR. Twenty-two year experience with recurring subareolar abscess andlactiferous duct fistula treated by a single breast surgeon. Am J Surg 2004; 188:407.</a></li><li class=\"breakAll\">Dixon JM, Bundred NJ. Management of disorders of the ductal system and infections. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.47.</li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/9\" class=\"nounderline abstract_t\">Dixon JM. Periductal mastitis and duct ectasia: an update. The Breast 1998; 7:128.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/10\" class=\"nounderline abstract_t\">Dixon JM, Thompson AM. Effective surgical treatment for mammary duct fistula. Br J Surg 1991; 78:1185.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/11\" class=\"nounderline abstract_t\">Gollapalli V, Liao J, Dudakovic A, et al. Risk factors for development and recurrence of primary breast abscesses. J Am Coll Surg 2010; 211:41.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/12\" class=\"nounderline abstract_t\">Bharat A, Gao F, Aft RL, et al. Predictors of primary breast abscesses and recurrence. World J Surg 2009; 33:2582.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/13\" class=\"nounderline abstract_t\">Dixon JM. Periductal mastitis/duct ectasia. World J Surg 1989; 13:715.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/14\" class=\"nounderline abstract_t\">Greydanus DE, Matytsina L, Gains M. Breast disorders in children and adolescents. Prim Care 2006; 33:455.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/15\" class=\"nounderline abstract_t\">Browning J, Bigrigg A, Taylor I. Symptomatic and incidental mammary duct ectasia. J R Soc Med 1986; 79:715.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/16\" class=\"nounderline abstract_t\">Schwartz GF. Benign neoplasms and &quot;inflammations&quot; of the breast. Clin Obstet Gynecol 1982; 25:373.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/17\" class=\"nounderline abstract_t\">Bundred NJ, Dixon JM, Lumsden AB, et al. Are the lesions of duct ectasia sterile? Br J Surg 1985; 72:844.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/18\" class=\"nounderline abstract_t\">Ammari FF, Yaghan RJ, Omari AK. Periductal mastitis. Clinical characteristics and outcome. Saudi Med J 2002; 23:819.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/19\" class=\"nounderline abstract_t\">Rahal RM, J&uacute;nior RF, Reis C, et al. Prevalence of bacteria in the nipple discharge of patients with duct ectasia. Int J Clin Pract 2005; 59:1045.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/20\" class=\"nounderline abstract_t\">Taffurelli M, Pellegrini A, Santini D, et al. Recurrent periductal mastitis: Surgical treatment. Surgery 2016; 160:1689.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/21\" class=\"nounderline abstract_t\">Dixon J, Lee E, Greenall M. Treatment of periareolar inflammation associated with periductal mastitis using metronidazole and flucloxacillin: A preliminary report. Br J Clin Pract 1988; 42:78.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/22\" class=\"nounderline abstract_t\">Dixon JM. Breast abscess. Br J Hosp Med (Lond) 2007; 68:315.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/23\" class=\"nounderline abstract_t\">Komenaka IK, Pennington RE Jr, Bowling MW, et al. A technique to prevent recurrence of lactiferous duct fistula. J Am Coll Surg 2006; 203:253.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/24\" class=\"nounderline abstract_t\">Almasad JK. Mammary duct fistulae: classification and management. ANZ J Surg 2006; 76:149.</a></li><li class=\"breakAll\">Meguid M, Kort K, Numann P, Oler A. Subareolar breast abscess: the penultimate stage of the mammary duct-associated inflammatory disease sequence. In: The Breast, 4th edition, Bland K, Copeland III E (Eds), Elsevier, Philadelphia 2009. Vol 1, p.107.</li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/26\" class=\"nounderline abstract_t\">PATEY DH, THACKRAY AC. Pathology and treatment of mammary-duct fistula. Lancet 1958; 2:871.</a></li><li class=\"breakAll\">Dixon JM. Breast surgery. In: Infection in surgical practice, Taylor EW (Ed), Oxford Medical Publications, Oxford 1992. p.187.</li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/28\" class=\"nounderline abstract_t\">Wilson JP, Massoll N, Marshall J, et al. Idiopathic granulomatous mastitis: in search of a therapeutic paradigm. Am Surg 2007; 73:798.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/29\" class=\"nounderline abstract_t\">Going JJ, Anderson TJ, Wilkinson S, Chetty U. Granulomatous lobular mastitis. J Clin Pathol 1987; 40:535.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/30\" class=\"nounderline abstract_t\">Al-Khaffaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experience. J Am Coll Surg 2008; 206:269.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/31\" class=\"nounderline abstract_t\">Maffini F, Baldini F, Bassi F, et al. Systemic therapy as a first choice treatment for idiopathic granulomatous mastitis. J Cutan Pathol 2009; 36:689.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/32\" class=\"nounderline abstract_t\">Tuli R, O'Hara BJ, Hines J, Rosenberg AL. Idiopathic granulomatous mastitis masquerading as carcinoma of the breast: a case report and review of the literature. Int Semin Surg Oncol 2007; 4:21.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/33\" class=\"nounderline abstract_t\">N&eacute;el A, Hello M, Cottereau A, et al. Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study. QJM 2013; 106:433.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/34\" class=\"nounderline abstract_t\">Tauch A, Fern&aacute;ndez-Natal I, Soriano F. A microbiological and clinical review on Corynebacterium kroppenstedtii. Int J Infect Dis 2016; 48:33.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/35\" class=\"nounderline abstract_t\">Taylor GB, Paviour SD, Musaad S, et al. A clinicopathological review of 34 cases of inflammatory breast disease showing an association between corynebacteria infection and granulomatous mastitis. Pathology 2003; 35:109.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/36\" class=\"nounderline abstract_t\">Troxell ML, Gordon NT, Doggett JS, et al. Cystic Neutrophilic Granulomatous Mastitis: &thinsp;Association With Gram-Positive Bacilli and Corynebacterium. Am J Clin Pathol 2016; 145:635.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/37\" class=\"nounderline abstract_t\">Dobinson HC, Anderson TP, Chambers ST, et al. Antimicrobial Treatment Options for Granulomatous Mastitis Caused by Corynebacterium Species. J Clin Microbiol 2015; 53:2895.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/38\" class=\"nounderline abstract_t\">Johnstone KJ, Robson J, Cherian SG, et al. Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including Corynebacterium kroppenstedtii. Pathology 2017; 49:405.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/39\" class=\"nounderline abstract_t\">Wong SCY, Poon RWS, Chen JHK, et al. Corynebacterium kroppenstedtii Is an Emerging Cause of Mastitis Especially in Patients With Psychiatric Illness on Antipsychotic Medication. Open Forum Infect Dis 2017; 4:ofx096.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/40\" class=\"nounderline abstract_t\">Lai EC, Chan WC, Ma TK, et al. The role of conservative treatment in idiopathic granulomatous mastitis. Breast J 2005; 11:454.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/41\" class=\"nounderline abstract_t\">Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol 1972; 58:642.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/42\" class=\"nounderline abstract_t\">Han BK, Choe YH, Park JM, et al. Granulomatous mastitis: mammographic and sonographic appearances. AJR Am J Roentgenol 1999; 173:317.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/43\" class=\"nounderline abstract_t\">Fletcher A, Magrath IM, Riddell RH, Talbot IC. Granulomatous mastitis: a report of seven cases. J Clin Pathol 1982; 35:941.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/44\" class=\"nounderline abstract_t\">Gombos EC, et al. Granulomatous mastitis. J Women's Imaging 2004; 6:136.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/45\" class=\"nounderline abstract_t\">Ozurk M, et al. Granulomatous mastitis: Radiologic findings. Acta Radiologica 1997; 48:150.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/46\" class=\"nounderline abstract_t\">Aldaqal SM. Idiopathic granulomatous mastitis. Clinical presentation, radiological features and treatment. Saudi Med J 2004; 25:1884.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/47\" class=\"nounderline abstract_t\">Memis A, Bilgen I, Ustun EE, et al. Granulomatous mastitis: imaging findings with histopathologic correlation. Clin Radiol 2002; 57:1001.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/48\" class=\"nounderline abstract_t\">Sabat&eacute; JM, Clotet M, G&oacute;mez A, et al. Radiologic evaluation of uncommon inflammatory and reactive breast disorders. Radiographics 2005; 25:411.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/49\" class=\"nounderline abstract_t\">Yilmaz E, Lebe B, Usal C, Balci P. Mammographic and sonographic findings in the diagnosis of idiopathic granulomatous mastitis. Eur Radiol 2001; 11:2236.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/50\" class=\"nounderline abstract_t\">Bouton ME, Jayaram L, O'Neill PJ, et al. Management of idiopathic granulomatous mastitis with observation. Am J Surg 2015; 210:258.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/51\" class=\"nounderline abstract_t\">Naraynsingh V, Hariharan S, Dan D, et al. Conservative management for idiopathic granulomatous mastitis mimicking carcinoma: case reports and literature review. Breast Dis 2010; 31:57.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/52\" class=\"nounderline abstract_t\">Munot K, Nicholson S, Birkett V. Granulomatous mastitis - A novel method of treatment. Eur J Surg Oncol 2012; 38:461.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/53\" class=\"nounderline abstract_t\">Akbulut S, Arikanoglu Z, Senol A, et al. Is methotrexate an acceptable treatment in the management of idiopathic granulomatous mastitis? Arch Gynecol Obstet 2011; 284:1189.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/54\" class=\"nounderline abstract_t\">Schmajuk G, Genovese MC. First report of idiopathic granulomatous mastitis treated with methotrexate monotherapy. J Rheumatol 2009; 36:1559.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/55\" class=\"nounderline abstract_t\">Sheybani F, Sarvghad M, Naderi HR, Gharib M. Treatment for and clinical characteristics of granulomatous mastitis. Obstet Gynecol 2015; 125:801.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/56\" class=\"nounderline abstract_t\">Pandey TS, Mackinnon JC, Bressler L, et al. Idiopathic granulomatous mastitis--a prospective study of 49 women and treatment outcomes with steroid therapy. Breast J 2014; 20:258.</a></li><li><a href=\"https://www.uptodate.com/contents/nonlactational-mastitis-in-adults/abstract/57\" class=\"nounderline abstract_t\">Akbulut S, Yilmaz D, Bakir S. Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases. Breast J 2011; 17:661.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 794 Version 24.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1001730\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">PERIDUCTAL MASTITIS</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">Clinical manifestations</a></li><li><a href=\"#H12090387\" id=\"outline-link-H12090387\">Differential diagnosis</a></li><li><a href=\"#H12091176\" id=\"outline-link-H12091176\">Microbiology</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Management</a><ul><li><a href=\"#H12093066\" id=\"outline-link-H12093066\">- Periductal mastitis</a></li><li><a href=\"#H7391701\" id=\"outline-link-H7391701\">- Subareolar abscess and periareolar fistula</a></li></ul></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">IDIOPATHIC GRANULOMATOUS MASTITIS</a><ul><li><a href=\"#H59659171\" id=\"outline-link-H59659171\">Clinical manifestations</a></li><li><a href=\"#H59659178\" id=\"outline-link-H59659178\">Diagnosis</a></li><li><a href=\"#H59659186\" id=\"outline-link-H59659186\">Management</a></li></ul></li><li><a href=\"#H1001730\" id=\"outline-link-H1001730\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/794|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PC/76304\" class=\"graphic graphic_picture\">- Periaerolar abscess </a></li><li><a href=\"image.htm?imageKey=PC/78199\" class=\"graphic graphic_picture\">- Mammary duct fistula</a></li><li><a href=\"image.htm?imageKey=PC/58118\" class=\"graphic graphic_picture\">- Fistulotomy</a></li><li><a href=\"image.htm?imageKey=PC/65757\" class=\"graphic graphic_picture\">- Post-fistula excision with transverse incision</a></li><li><a href=\"image.htm?imageKey=PC/75481\" class=\"graphic graphic_picture\">- Post-fistula excision with a circumareolar incision</a></li><li><a href=\"image.htm?imageKey=SURG/57055\" class=\"graphic graphic_picture\">- Nipple inversion associated with duct ectasia</a></li><li><a href=\"image.htm?imageKey=PC/51199\" class=\"graphic graphic_picture\">- Idiopathic granulomatous mastitis</a></li></ul></li><li><div id=\"ID/794|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/53504\" class=\"graphic graphic_table\">- Risk factors for MRSA colonization</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-women-with-suspected-breast-cancer\" class=\"medical medical_review\">Diagnostic evaluation of women with suspected breast cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lactational-mastitis\" class=\"medical medical_review\">Lactational mastitis</a></li></ul></div></div>","javascript":null}